Hidradenitis Suppurativa Prevalence in Nuuk, Greenland: Physician Validation of a Hidradenitis Suppurativa Questionnaire in a Greenlandic Setting

Sofia H.C. Botvid; Lone Storgaard Hove; Dorra Bouazzi; Rune Kjærsgaard Andersen; Simon Francis Thomsen; Ditte Marie Saunte; Gregor B.E. Jemec

doi:10.2340/actadv.v103.4410

Hidradenitis Suppurativa Prevalence in Nuuk, Greenland: Physician Validation of a Hidradenitis Suppurativa Questionnaire in a Greenlandic Setting

Sofia H.C. Botvid^*, Lone Storgaard Hove, Dorra Bouazzi, Rune Kjærsgaard Andersen, Simon Francis Thomsen, Ditte Marie Saunte, Gregor B.E. Jemec

^*Corresponding author for this work

Research output: Contribution to journal › Journal article › Research › peer-review

13 Citations (Scopus)

36 Downloads (Pure)

Original language	English
Article number	adv00847
Journal	Acta Dermato-Venereologica
Volume	103
ISSN	0001-5555
DOIs	https://doi.org/10.2340/actadv.v103.4410
Publication status	Published - 2023

Access to Document

10.2340/actadv.v103.4410Licence: CC BY-NC

FulltextFinal published version, 598 KBLicence: CC BY-NC

Cite this

Hidradenitis Suppurativa Prevalence in Nuuk, Greenland : Physician Validation of a Hidradenitis Suppurativa Questionnaire in a Greenlandic Setting. / Botvid, Sofia H.C.; Hove, Lone Storgaard; Bouazzi, Dorra; Andersen, Rune Kjærsgaard ; Thomsen, Simon Francis ; Saunte, Ditte Marie ; Jemec, Gregor B.E.

In: Acta Dermato-Venereologica, Vol. 103, adv00847, 2023.

Research output: Contribution to journal › Journal article › Research › peer-review

@article{3d9b150cef8f4bc694e6e41c980d6ce7,

title = "Hidradenitis Suppurativa Prevalence in Nuuk, Greenland: Physician Validation of a Hidradenitis Suppurativa Questionnaire in a Greenlandic Setting",

author = "Botvid, {Sofia H.C.} and Hove, {Lone Storgaard} and Dorra Bouazzi and Andersen, {Rune Kj{\ae}rsgaard} and Thomsen, {Simon Francis} and Saunte, {Ditte Marie} and Jemec, {Gregor B.E.}",

note = "Funding Information: The study was supported by the Greenlandic Research Foundation for Medical Doctors in Greenland. We would especially like to thank our Greenlandic colleagues Aviannguaq Kreutzmann and Trine Pedersen Abelsen for their indispensable contribution to this study. This study could not have been conducted without their translations and knowledge of the Greenlandic Inuit language. We would also like to thank all the patients, who let us examine them and take clinical photographs of their skin conditions. Conflicts of interest: DB: UCB Nordic has paid for EADV congress participation. RKA: Eli Lilly has paid for NCDV 2022 congress participation. SFT has been a speaker or advisor for Sanofi, AbbVie, LEO Pharma, Pfizer, Eli Lilly, Novartis, UCB Pharma, Almirall, Union Therapeutics, and Janssen Pharmaceuticals; and has received research support from Sanofi, AbbVie, LEO Pharma, Novartis, UCB Pharma, and Janssen Pharmaceuticals, outside the submitted work. DMS received honoraria as a consultant for advisory board meetings by AbbVie, Janssen, Sanofi, LeoPharma and as a speaker and/or received grants from the following companies: Abbvie, Janssen, Novartis, Sanofi and Leo Pharma during the last 3 years. GBEJ has received research funding and/or honoraria from Abbvie, InflRx, Janssen-Cilag, Leo Pharma, Novartis, ChemoCentryx, Regeneron and Serono. The other authors have no conflicts of interest to declare.",

year = "2023",

doi = "10.2340/actadv.v103.4410",

language = "English",

volume = "103",

journal = "Acta Dermato-Venereologica",

issn = "0001-5555",

publisher = "Society for the Publication of Acta Dermato - Venereologica",

}

TY - JOUR

T1 - Hidradenitis Suppurativa Prevalence in Nuuk, Greenland

T2 - Physician Validation of a Hidradenitis Suppurativa Questionnaire in a Greenlandic Setting

AU - Botvid, Sofia H.C.

AU - Hove, Lone Storgaard

AU - Bouazzi, Dorra

AU - Andersen, Rune Kjærsgaard

AU - Thomsen, Simon Francis

AU - Saunte, Ditte Marie

AU - Jemec, Gregor B.E.

N1 - Funding Information: The study was supported by the Greenlandic Research Foundation for Medical Doctors in Greenland. We would especially like to thank our Greenlandic colleagues Aviannguaq Kreutzmann and Trine Pedersen Abelsen for their indispensable contribution to this study. This study could not have been conducted without their translations and knowledge of the Greenlandic Inuit language. We would also like to thank all the patients, who let us examine them and take clinical photographs of their skin conditions. Conflicts of interest: DB: UCB Nordic has paid for EADV congress participation. RKA: Eli Lilly has paid for NCDV 2022 congress participation. SFT has been a speaker or advisor for Sanofi, AbbVie, LEO Pharma, Pfizer, Eli Lilly, Novartis, UCB Pharma, Almirall, Union Therapeutics, and Janssen Pharmaceuticals; and has received research support from Sanofi, AbbVie, LEO Pharma, Novartis, UCB Pharma, and Janssen Pharmaceuticals, outside the submitted work. DMS received honoraria as a consultant for advisory board meetings by AbbVie, Janssen, Sanofi, LeoPharma and as a speaker and/or received grants from the following companies: Abbvie, Janssen, Novartis, Sanofi and Leo Pharma during the last 3 years. GBEJ has received research funding and/or honoraria from Abbvie, InflRx, Janssen-Cilag, Leo Pharma, Novartis, ChemoCentryx, Regeneron and Serono. The other authors have no conflicts of interest to declare.

PY - 2023

Y1 - 2023

U2 - 10.2340/actadv.v103.4410

DO - 10.2340/actadv.v103.4410

M3 - Journal article

C2 - 36625210

AN - SCOPUS:85145957209

VL - 103

JO - Acta Dermato-Venereologica

JF - Acta Dermato-Venereologica

SN - 0001-5555

M1 - adv00847

ER -